Artificial Intelligence in Infectious Diseases and Healthcare: Building Bridges to a Real-Time, Learning Health System (CE Session)
Includes a Live Web Event on 04/30/2025 at 11:55 AM (PDT)
Description:
Artificial intelligence (AI) is transforming healthcare by enabling real-time data analysis, predictive modeling, and decision support. This session explores how different types of AI can be leveraged to enhance infectious disease management and strengthen healthcare systems. Participants will examine the challenges of AI implementation, from data integration to ethical considerations, and identify practical strategies to overcome these obstacles. The session will also highlight AI-driven risk prediction models as a tool for optimizing infection management, improving patient outcomes, and advancing evidence-based practice.
This session is part of the Sepsis Alliance AMR Conference 2025.
Learning Objectives:
At the end of the session, the learner should be able to:
- Differentiate various types of artificial intelligence (AI) and analyze their potential applications in healthcare settings
- Evaluate key barriers, challenges, and risks associated with implementing artificial intelligence in healthcare and propose practical solutions to address them
- Apply AI-driven risk prediction strategies to support the uptake of evidence-based infection management in healthcare settings
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Westyn Branch-Elliman, MD, MMSc, FSHEA, FIDSA
Acting Director, Health Sciences-AI; Chief, Section of Infectious Diseases; Professor of Medicine at the UCLA David Geffen School of Medicine
Veteran Affairs Digital Health Office; Greater LA VA Medical Center; UCLA David Geffen School of Medicine
Westyn Branch-Elliman, MD, MMSc, FSHEA, FIDSA, is the Acting Director of Health Sciences-AI in the VA Digital Health Office, Chief in the Section of Infectious Diseases at the Greater LA VA Medical Center, and a Professor of Medicine at the UCLA David Geffen School of Medicine. She is an established clinician investigator and VA research PI with expertise in dissemination and implementation science, epidemiology, policy evaluation, leveraging VA databases to support automated surveillance activities, and rapid response research to support learning healthcare systems initiatives that translate big data into bedside impact. In her current role as Acting Director of Health Sciences-AI, Dr. Branch-Elliman works to rapidly integrate new and emerging technology to improve bedside care.
During the COVID-19 pandemic, she led a multicenter therapeutics clinical trial and served as a scientific policy advisor to the Massachusetts Department of Elementary and Secondary Education, providing support for the design and implementation of the state-wide Test-to-Stay Modified Quarantine Program in addition to other in-school testing programs. She is formerly the Medical Director of Infection Prevention and Antimicrobial Stewardship at the Eastern Colorado VA Healthcare System and an associate editor of Infection Control and Hospital Epidemiology, the major journal of the Society for Healthcare Epidemiology in America.